Ocera医疗
OCRX

股本结构

单位：万股
公告日期 2017-11-14 2017-08-01 2017-05-09 2017-05-09 2017-03-14 2016-11-02
证券总股本 2651.41 2651.01 2651.01 2596.28 2360.02 2314.39
普通股本 2651.41 2651.01 2651.01 2596.28 2360.02 2314.39
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2017-09-30 2017-06-30 2017-04-30 2017-03-31 2016-12-31 2016-10-31
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2017-11-14 2651.41 未披露 定期报告 2017-09-30
2017-08-01 2651.01 未披露 定期报告 2017-06-30
2017-05-09 2651.01 未披露 定期报告 2017-04-30
2017-05-09 2596.28 未披露 定期报告 2017-03-31
2017-03-14 2360.02 未披露
更多>>
From December 31, 2015 to December 31, 2016 Issuance of common stock, net of issuance cost Issuance of common stock upon exercise of stock options Issuance of common stock upon cashless exercise of stock warrants
2016-12-31
2016-11-02 2314.39 未披露 定期报告 2016-10-31
2016-11-02 2307.58 未披露 定期报告 2016-09-30
2016-08-04 2185.15 未披露 定期报告 2016-07-29
2016-08-04 2183.95 未披露 定期报告 2016-06-30
2016-05-03 2130.71 未披露 定期报告 2016-03-31
2016-03-11 2130.71 未披露 定期报告 2016-02-29
2016-03-11 2069.52 未披露
更多>>
From December 31, 2014 to December 31, 2015 Issuance of common stock, net of issuance cost Issuance of common stock upon cashless exercise of stock warrants
2015-12-31
2015-11-05 2050.32 未披露 定期报告 2015-10-31
2015-11-05 2042.49 未披露 定期报告 2015-09-30
2015-08-10 1988.42 未披露 定期报告 2015-06-30
2015-03-13 1974.74 未披露
更多>>
from December 31, 2013 to December 31, 2014 Issuance of common stock, net of issuance cost Issuance of common stock upon exercise of stock options Issuance of common stock upon cashless exercise of stock options Issuance of common stock upon cashless exercise of stock warrants
2014-12-31
2014-11-13 1974.18 未披露 定期报告 2014-09-30
2014-08-13 1974.18 未披露 定期报告 2014-07-31
2014-08-13 1554.18 未披露 定期报告 2014-06-30
2014-04-29 1554.16 未披露 定期报告 2014-04-25
2014-05-13 1552.37 未披露 定期报告 2014-03-31
2014-03-18 1545.34 未披露 定期报告 2014-03-14
2014-03-18 1530.02 未披露
更多>>
from December 31, 2012 to December 31, 2013 Conversion of preferred stock to common stock Shares issued in merger with Tranzyme Issuance of common stock for cash of $48,000, net of issuance costs of $1,575 Issuance of common stock upon exercise of stock options
2013-12-31
2013-11-15 1523.20 未披露 定期报告 2013-11-11
2013-11-14 1524.78 未披露 定期报告 2013-11-08
2013-11-14 1129.11 未披露
更多>>
from December 31, 2012 to September 30, 2013 Conversion of promissory note and accrued interest Conversion of convertible preferred stock Held by Tranzyme shareholders upon completion of merger Issued pursuant to Financing Agreement Exercise of common stock options
2013-09-30
2013-08-14 1128.79 未披露
更多>>
After giving effect to the Merger and the Financing, the Company had 11,287,943 shares of common Stock outstanding.
2013-08-01
2013-08-14 230.00 未披露
更多>>
On July 15, 2013, Tranzyme effected a 12-to-1 reverse stock split on its issued and outstanding common stock.
2013-07-16
2013-03-28 2760.04 未披露
更多>>
from December 31, 2011 to September 30,2012 Issuance of common stock upon exercise of options for cash Issuance of common stock in direct offering
2012-09-30
2012-08-10 2461.34 未披露 定期报告 2012-08-03
2012-05-11 2460.79 未披露 定期报告 2012-03-31
2012-02-29 2459.78 未披露
更多>>
from December 31, 2010 to December 31, 2011 Conversion of preferred stock to common stock in initial public offering Issuance of common stock in initial public offering Issuance of common stock upon exercise of stock options for cash
2011-12-31
2011-08-11 2455.88 未披露 定期报告 2011-06-30
2011-05-12 27.91 6950.88 定期报告 2011-03-31
From December 31, 2015 to December 31, 2016 Issuance of common stock, net of issuance cost Issuance of common stock upon exercise of stock options Issuance of common stock upon cashless exercise of stock warrants
From December 31, 2014 to December 31, 2015 Issuance of common stock, net of issuance cost Issuance of common stock upon cashless exercise of stock warrants
from December 31, 2013 to December 31, 2014 Issuance of common stock, net of issuance cost Issuance of common stock upon exercise of stock options Issuance of common stock upon cashless exercise of stock options Issuance of common stock upon cashless exercise of stock warrants
from December 31, 2012 to December 31, 2013 Conversion of preferred stock to common stock Shares issued in merger with Tranzyme Issuance of common stock for cash of $48,000, net of issuance costs of $1,575 Issuance of common stock upon exercise of stock options
from December 31, 2012 to September 30, 2013 Conversion of promissory note and accrued interest Conversion of convertible preferred stock Held by Tranzyme shareholders upon completion of merger Issued pursuant to Financing Agreement Exercise of common stock options
After giving effect to the Merger and the Financing, the Company had 11,287,943 shares of common Stock outstanding.
On July 15, 2013, Tranzyme effected a 12-to-1 reverse stock split on its issued and outstanding common stock.
from December 31, 2011 to September 30,2012 Issuance of common stock upon exercise of options for cash Issuance of common stock in direct offering
from December 31, 2010 to December 31, 2011 Conversion of preferred stock to common stock in initial public offering Issuance of common stock in initial public offering Issuance of common stock upon exercise of stock options for cash
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。